T4 lysozyme mutant l99a Deposition Author(s): Balius, T.E. , Kamenik, A.S. , Lak, P. , Liedl, K.R. , Shoichet, B.K. , Singh, I.
Date: 2021-03-03 Method: X-RAY DIFFRACTION Resolution: 1.07 Å Organism(s): Enterobacteria Phage T4 Sequences Data: 7LXA_A
Structure of human serotonin transporter bound to small molecule '8090 in lipid nanodisc and nacl Deposition Author(s): Basbaum, A.I. , Bekele, B. , Billesboelle, C.B. , Boytsov, D. , Braz, J. , Craik, V. , Huang, X.P. , Lak, P. , Manglik, A. , O'Donnell, H. , Rodriguiz, R.M. , Roth, B.L. , Roy, K. , Rudnick, G. , Sandtner, W. , Seth, A. , Shoichet, B.K. , Singh, I. , Wetsel, W.C.
Date: 2022-02-09 Method: ELECTRON MICROSCOPY Resolution: 3.0 Å Organism(s): Homo Sapiens , Mus Musculus Sequences Data: 7TXT_C , 7TXT_D , 7TXT_S
Cryo-em structure of the alpha2a adrenergic receptor goa signaling complex bound to a g protein biased agonist Deposition Author(s): Du, Y. , Fink, E.A. , Shoichet, B.K. , Xu, J.
Date: 2021-12-02 Method: ELECTRON MICROSCOPY Resolution: 3.47 Å Organism(s): Homo Sapiens , Mus Musculus Sequences Data: 7W6P_A , 7W6P_B , 7W6P_G , 7W6P_H , 7W6P_R
Cryo-em structure of the alpha2a adrenergic receptor goa signaling complex bound to a biased agonist Deposition Author(s): Du, Y. , Fink, E.A. , Shoichet, B.K. , Xu, J.
Date: 2021-12-04 Method: ELECTRON MICROSCOPY Resolution: 3.4 Å Organism(s): Homo Sapiens , Mus Musculus Sequences Data: 7W7E_A , 7W7E_B , 7W7E_G , 7W7E_H , 7W7E_R
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 2.17 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DIB_A , 8DIB_B
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 2.09 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DIC_A , 8DIC_B
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DID_A , 8DID_B
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DIE_A , 8DIE_B
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 1.98 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DIF_A , 8DIF_B
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors Deposition Author(s): Shoichet, B.K. , Singh, I.
Date: 2022-06-29 Method: X-RAY DIFFRACTION Resolution: 2.45 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8DIG_A , 8DIG_B